Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02506543 · ClinicalTrials.gov registry record · NA

Creating Opportunities Through Mentoring, Parental Involvement and Safe Spaces - Ethiopia

A NA study of Domestic Violence and Sexual Assault, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
1,014
Enrollment target
2
Study locations

NCT02506543: Completed NA study of Domestic Violence and Sexual Assault, sponsored by Columbia University.

NCT02506543 is a NA study of Domestic Violence and Sexual Assault that has completed, run by Columbia University. The registered enrollment target is 1,014 participants, above the 384-participant average among 12 other Domestic Violence trials with a reported enrollment target (164% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02506543, a NA study of Domestic Violence and Sexual Assault, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
1,014 participants
Enrollment target
2
Study locations

Study Summary

The study is a randomized controlled trial of COMPASS, an intervention for adolescent girls in three refugee camps in Ethiopia. The study design will employ a two group wait-list cluster randomized controlled trial where girls will be invited to participate in the COMPASS program, assigned to groups of approximately 20 for the purposes of the program, complete a pre-test baseline assessment, and will then be randomized by group to the intervention or control condition. In addition, qualitative research will address additional questions of acceptability, processes of change and best practice. Groups in three refugee camps - Sherkole, Bambasi, and Tongo - will be randomized to determine whether the participants receive the intervention or are placed on the wait-list immediately following the baseline. Those that do not get the curriculum during the study will receive it following the endline phase of the study so as to not create tensions or jealousies. The intervention, the COMPASS program, will involve a structured intervention for girls between the ages of 13-19 that is intended to engage adolescent girls, those who are influential in their lives, service providers and other stakeholders, with the ultimate goal of co-creating environments in which girls are valued and safe. The program is centered on establishing or supporting community-supported safe spaces for girls where they can come and gather among themselves and participate in a structured life-skills curriculum.

Primary Outcome

A binary composite representing any form of sexual violence in the previous 12 months, which included self-reported forced sex, unwanted sexual touching, or coerced sex

Interventions

  • BEHAVIORAL COMPASS
  • BEHAVIORAL No intervention

Study Locations (2)

New York

  • Columbia University - New York

Other

  • International Rescue Committee - Addis Ababa

Trial Details

FieldValue
Enrollment Target 1,014 participants
Start Date 2015-08
Est. Completion 2016-09
Phase NA
Columbia University

958 total trials

What the finished NCT02506543 record still lists

NCT02506543 is an interventional study that assigns participants to a tested intervention. Its 1,014 participants enrollment target places it among the larger protocols in the corpus, above the 384-participant average among 12 other Domestic Violence trials with a reported enrollment target (164% higher).

The record links to 4 conditions, with Domestic Violence appearing as the primary indexed condition, and to 2 interventions - of which COMPASS is the first listed.

NCT02506543 reports a single indexed study location in New York, Other.

Frequently Asked Questions

What is clinical trial NCT02506543 about?

NCT02506543 is a clinical study titled "Creating Opportunities Through Mentoring, Parental Involvement and Safe Spaces - Ethiopia". The study is a randomized controlled trial of COMPASS, an intervention for adolescent girls in three refugee camps in Ethiopia. The study design will employ a two group wait-list cluster randomized controlled trial where girls will be invited to participate in the COMPASS program, assigned to groups...

What is the current status of trial NCT02506543?

This trial is currently completed. It is a NA study. The enrollment target is 1,014 participants. The study started on 2015-08. Estimated completion is 2016-09.

What conditions does trial NCT02506543 study?

This clinical trial studies the following conditions: Domestic Violence, Sexual Assault, Interpersonal Relations, Marital Status.

What interventions are being tested in trial NCT02506543?

The interventions under investigation include: COMPASS (BEHAVIORAL), No intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02506543?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02506543 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Domestic Violence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02506543's enrollment target sits among peer trials

1,014 2nd of 12 the highest of 12 other Domestic Violence trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Domestic Violence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06146738 · 1,015 participants

    The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)

  • NCT06608823 · 1,016 participants · NA

    ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™

  • NCT06549595 · 1,018 participants · Phase 3

    A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

  • NCT02178163 · 1,020 participants · NA

    Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02506543, the US trial registry maintained by the National Library of Medicine. NCT02506543 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.